INTRODUCTION: Basal-like breast cancers behave more aggressively despite the presence of a dense lymphoid infiltrate. We hypothesised that immune suppression in this subtype may be due to T regulatory cells (Treg) recruitment driven by hypoxia-induced up-regulation of CXCR4 in Treg. METHODS: Immunoperoxidase staining for FOXP3 and CXCL12 was performed on tissue microarrays from 491 breast cancers. The hypoxia-associated marker carbonic anhydrase IX (CA9) and double FOXP3/CXCR4 staining were performed on sections from a subset of these cancers including 10 basal-like and 11 luminal cancers matched for tumour grade. RESULTS: High Treg infiltration correlated with tumour CXCL12 positivity (OR 1.89, 95% CI 1.22 to 2.94, P = 0.004) and basal phe...
<p>Interactions between immune and tumor cells in the tumor microenvironment (TME) often impact pati...
International audienceTumor-draining lymph node (TDLN) invasion by metastatic cells in breast cancer...
IMPORTANCE OF THE FIELD: The active suppression of immune responses against tumor is a major barrier...
INTRODUCTION: Basal-like breast cancers behave more aggressively despite the presence of a dense lym...
Purpose: Cutaneous squamous cell carcinoma (cSCC) is the most common human cancer with metastatic po...
Background: Breast cancer is one of the most common cancers in western women. The cancer stem cell h...
PURPOSE: To assess the clinical significance of tumor-infiltrating FOXP3-positive regulatory T cells...
<p>Interactions between immune and tumor cells in the tumor microenvironment (TME) often impact pati...
Background: Cancer stem cell (CSC) hypothesis postulates that tumors are maintained by a self-renewi...
<p>Interactions between immune and tumor cells in the tumor microenvironment (TME) often impact pati...
Breast cancer is the most common cancer in women worldwide and the second most common cancer overall...
Basal-like tumours account for 15% of invasive breast carcinomas and are associated with a poorer pr...
Background/Aims: Hypoxia occurs in many pathological conditions, including inflammation and cancer. ...
The immune system plays a dual role in cancer development. Besides the potential to eliminate cancer...
Regulatory T cell (Treg)-mediated immunosuppression represents one of the crucial tumor immune evasi...
<p>Interactions between immune and tumor cells in the tumor microenvironment (TME) often impact pati...
International audienceTumor-draining lymph node (TDLN) invasion by metastatic cells in breast cancer...
IMPORTANCE OF THE FIELD: The active suppression of immune responses against tumor is a major barrier...
INTRODUCTION: Basal-like breast cancers behave more aggressively despite the presence of a dense lym...
Purpose: Cutaneous squamous cell carcinoma (cSCC) is the most common human cancer with metastatic po...
Background: Breast cancer is one of the most common cancers in western women. The cancer stem cell h...
PURPOSE: To assess the clinical significance of tumor-infiltrating FOXP3-positive regulatory T cells...
<p>Interactions between immune and tumor cells in the tumor microenvironment (TME) often impact pati...
Background: Cancer stem cell (CSC) hypothesis postulates that tumors are maintained by a self-renewi...
<p>Interactions between immune and tumor cells in the tumor microenvironment (TME) often impact pati...
Breast cancer is the most common cancer in women worldwide and the second most common cancer overall...
Basal-like tumours account for 15% of invasive breast carcinomas and are associated with a poorer pr...
Background/Aims: Hypoxia occurs in many pathological conditions, including inflammation and cancer. ...
The immune system plays a dual role in cancer development. Besides the potential to eliminate cancer...
Regulatory T cell (Treg)-mediated immunosuppression represents one of the crucial tumor immune evasi...
<p>Interactions between immune and tumor cells in the tumor microenvironment (TME) often impact pati...
International audienceTumor-draining lymph node (TDLN) invasion by metastatic cells in breast cancer...
IMPORTANCE OF THE FIELD: The active suppression of immune responses against tumor is a major barrier...